Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03456141 · ClinicalTrials.gov registry record
Multimodal Analgesic Protocol to Moderate Acute Pain
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 100
- Enrollment target
NCT03456141: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT03456141 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03456141 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
With a prospective, observational study assess post-surgery pain levels and patient's use of opioids and other analgesic drugs to moderate pain following third molar surgery.
Primary Outcome
Likert scales for average pain and worst pain are assessed with 7-point scales with verbal anchors of "no pain" and "worst pain imagined". Recovery for pain on the Likert scales is defined as the number of PSD until the patient reports a score of 1 or 2 on the 7-point scale.
Interventions
- PROCEDURE third molar surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2022-12-31 |
What the finished NCT03456141 record still lists
NCT03456141 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which third molar surgery is the first listed.
NCT03456141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03456141 about?
NCT03456141 is a clinical study titled "Multimodal Analgesic Protocol to Moderate Acute Pain". With a prospective, observational study assess post-surgery pain levels and patient's use of opioids and other analgesic drugs to moderate pain following third molar surgery.
What is the current status of trial NCT03456141?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-03-01. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03456141?
The interventions under investigation include: third molar surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03456141?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI